Publications

Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study.

Carrim, M; Tempia, S; THINDWA, D; Martinson, NA; Kahn, K; FLASCHE, S; Hellferscee, O; Treurnicht, FK; McMorrow, ML; Moyes, J; Mkhencele, T; Mathunjwa, A; Kleynhans, J; Lebina, L; Mothlaoleng, K; Wafawanaka, F; Gómez-Olivé, FX; Cohen, C; Von Gottberg, A; Wolter, N; PHIRST group,;

2022

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2022).76 3 10.1093/cid/ciac499.

Estimating RSV seasonality from pandemic disruptions: a modelling study.

KRAUER, F; Fjelde, TE; KOLTAI, M; HODGSON, D; Treskova-Schwarzbach, M; Harvey, C; JIT, M; Wichmann, O; Harder, T; Flasche, S;

2022

medRxiv (2022). 10.1101/2022.06.18.22276591.

Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations.

SHERRATT, K; Gruson, H; Grah, R; Johnson, H; Niehus, R; Prasse, B; Sandman, F; Deuschel, J; Wolffram, D; ABBOTT, S; Ullrich, A; Gibson, G; Ray, EL; Reich, NG; Sheldon, D; Wang, Y; Wattanachit, N; Wang, L; Trnka, J; Obozinski, G; Sun, T; Thanou, D; Pottier, L; Krymova, E; Barbarossa, MV; ... FUNK, S.

2022

medRxiv (2022). 10.1101/2022.06.16.22276024.

Cycle threshold values in symptomatic COVID-19 cases in England.

FUNK, S; ABBOTT, S;

2022

medRxiv (2022). 10.1101/2022.06.13.22276321.

The importance of the generation interval in investigating dynamics and control of new SARS-CoV-2 variants.

Park, SW; Bolker, BM; FUNK, S; Metcalf, CJ E; Weitz, JS; Grenfell, BT; Dushoff, J;

2022

Journal of the Royal Society. Interface, (2022).19 191 10.1098/rsif.2022.0173.

Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.

EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; SHAIKH, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; Houben, RM G J;

2022

medRxiv (2022). 10.1101/2022.06.09.22276188.

Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji.

REES, EM; Lau, CL; Kama, M; Reid, S; LOWE, R; KUCHARSKI, AJ;

2022

PLoS neglected tropical diseases, (2022).16 6 10.1371/journal.pntd.0010506.

Heavy-tailed sexual contact networks and the epidemiology of monkeypox outbreak in non-endemic regions, May 2022.

Endo, A; Murayama, H; ABBOTT, S; RATNAYAKE, R; PEARSON, C; EDMUNDS, J; FEARON, E; FUNK, S;

2022

medRxiv (2022). 10.1101/2022.06.13.22276353.

Vaccine equity in low and middle income countries: a systematic review and meta-analysis.

Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;

2022

International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

MacKenna, B; Kennedy, NA; Mehrkar, A; Rowan, A; Galloway, J; MATTHEWMAN, J; MANSFIELD, KE; Bechman, K; Yates, M; Brown, J; SCHULTZE, A; Norton, S; Walker, AJ; Morton, CE; Harrison, D; BHASKARAN, K; RENTSCH, CT; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Davy, S; Green, A; Fisher, L; ... LANGAN, SM.

2022

The Lancet Rheumatology, (2022).4 7 10.1016/S2665-9913(22)00098-4.